Acute renal failure associated with methotrexate chemotherapy

Yang Wei,Gu Jian
DOI: https://doi.org/10.3969/j.issn.1008-5734.2010.06.014
2010-01-01
Abstract:A 14-year-old girl with lymphom a stage Ⅳ was hospitalized and received her sixteenth course of chemotherapy.On admission,laboratory testing revealed the following levels: WBC count 5.58×10 9/L,Hb 88 g/L,PLT count 143×109/L,SCr 42 μmol/L,ALT 38 U/L.Her he art,liver and renal functions were almost normal.Methotrexate was given intrav enously according to the following protocol: a total methotrexate dose of 4 g,one third of the total dose within 0.5 hour,and then the remaining dose within 2 3.5 hours.Meanwhile,dexmethasone 5 mg,cytarabine 40 mg,and methotrexate 12.5 mg were administered intrathecally,and IV vincristine 1.8 mg was given.On day 2 of chemotherapy,the girl developed fever,vomiting,diarrhea and edema in her lower limbs.On day 3,laboratory investigations showed the following levels: WBC count 2.49×109/L,PLT count 24×109/L,Hb 58.0 g/L,potassium 2.74 mmol/L,SCr 179 μmol/l,CK 1 089 U/L.Her blood methotrexate concentratio ns 24 and 42 hours after chemotherapy completion were 168.0 and 65.0 μmol/L,respectively.During blood purification period,her blood methotrexate concentrati ons were 36.5 μmol/L(66 h),29.4 μmol/L(73 h),22.1 μmol/L(77 h) and 16.0 μmol/L(90 h).On day 5 of chemotherapy,her urine volume decreased to 460 mL, followed by anuria and convulsions.After receiving IV diazepam 5 mg,her convulsions was relieved,but she still had agitation.
What problem does this paper attempt to address?